Evidence map›Paper›PMID 39233331›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Diagnostic value for methylation in cervical cancer based on a small-molecule fluorescent probe targeting DNMT1.

Baohua Yang, Chao Xu, Hang Li, Xiuxiang Zhu, Ziyin Xia, Ling Xu, Qian Zhang

RetractedAbstract readRetracted Publication
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Diagnostic value for methylation in cervical cancer based on a small-molecule fluorescent probe targeting DNMT1.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Baohua YangDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Chao XuDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Hang LiDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Xiuxiang ZhuDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Ziyin XiaDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Ling XuDepartment of Obstetrics and Gynecology, Minhang Hospital, Fudan University, Shanghai, China.
Qian ZhangDepartment of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0000-1689-6962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundValue analysis of a small-molecule fluorescent probe for methylation detection in different cervical lesions. MATERIALS AND

methods(1) The grayscale values of distinct lesion tissues were remarkably distinct among the four groups (p < 0.05). The comparison of the grayscale value between the two groups showed that the CA group noticeably exceeded the LSIL and cervicitis groups, and the HSIL group was apparently higher than the LSIL and cervicitis groups (p < 0.05); (2) The mean grayscale values of the enrolled subjects were calculated with 55.21 as the midline, with >55.21 as positive and ≤55.21 as negative.

resultsThe results showed that the positive rate of the cervicitis group was 0.00%, the LSIL group 67.74%, the HSIL group 83.33%, and the CA group 100.00%. The results among the four groups were notably distinct (p < 0.05); (3) The comparison among DAPI, probe, bright, and merged images of cervicitis, LSIL, HSIL, and CA indicated that different cervical lesions were with quite various stains.

conclusionThe grayscale value, positive rate, and stained picture of distinct cervical lesions were remarkably different. The small-molecule fluorescent probe has a good value in differentiating cervical lesions and can be considered for popularization and application.

Indexed as

DNA (Cytosine-5-)-Methyltransferase 1DNA MethylationFluorescent DyesUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedSensitivity and SpecificityUterine Cervical DysplasiaUterine CervicitisDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanFluorescent Dyescervical cancerdiagnostic valuefluorescent probegenetic testing technologymethylationsmall‐molecule

Identifiers

PMID39233331
PMCPMC11374689

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.